It has been previously shown that BET inhibitors dissociated BRD4 from chromatin at the regulatory regions of multiple RTKs to reduce their expression level [32], thereby sensitizing a broad range of tumor cell lines to PI3K-Akt inhibitors [32]. Here, BRD4 is linked to neoplasm.